Literature DB >> 29278937

Unpacking Major Depressive Disorder: From Classification to Treatment Selection.

Sidney H Kennedy1,2,3,4, Amanda K Ceniti1,2.   

Abstract

Entities:  

Keywords:  biomarkers; heterogeneity; major depressive disorder

Mesh：

Substances：

Year:  2017        PMID： 29278937      PMCID： PMC5912302          DOI： 10.1177/0706743717748883

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN： 0706-7437            Impact factor:   4.356


× No keyword cloud information.
  58 in total

1.  The heterogeneity of the depressive syndrome: when numbers get serious.

Authors:  S D Ostergaard; S O W Jensen; P Bech
Journal:  Acta Psychiatr Scand       Date:  2011-08-13       Impact factor: 6.392

Review 2.  Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments.

Authors:  Sidney H Kennedy; Raymond W Lam; Roger S McIntyre; S Valérie Tourjman; Venkat Bhat; Pierre Blier; Mehrul Hasnain; Fabrice Jollant; Anthony J Levitt; Glenda M MacQueen; Shane J McInerney; Diane McIntosh; Roumen V Milev; Daniel J Müller; Sagar V Parikh; Norma L Pearson; Arun V Ravindran; Rudolf Uher
Journal:  Can J Psychiatry       Date:  2016-08-02       Impact factor: 4.356

3.  A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale.

Authors:  R P Snaith; M Hamilton; S Morley; A Humayan; D Hargreaves; P Trigwell
Journal:  Br J Psychiatry       Date:  1995-07       Impact factor: 9.319

4.  Development and validation of prediction algorithms for major depressive episode in the general population.

Authors:  Jian Li Wang; Douglas Manuel; Jeanne Williams; Norbert Schmitz; Heather Gilmour; Scott Patten; Glenda MacQueen; Arden Birney
Journal:  J Affect Disord       Date:  2013-06-19       Impact factor: 4.839

5.  Insomnia and objectively measured sleep disturbances predict treatment outcome in depressed patients treated with psychotherapy or psychotherapy-pharmacotherapy combinations.

Authors:  Wendy M Troxel; David J Kupfer; Charles F Reynolds; Ellen Frank; Michael E Thase; Jean M Miewald; Daniel J Buysse
Journal:  J Clin Psychiatry       Date:  2011-11-29       Impact factor: 4.384

6.  Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective study.

Authors:  H J Conradi; J Ormel; P de Jonge
Journal:  Psychol Med       Date:  2010-10-08       Impact factor: 7.723

7.  Resting-state connectivity biomarkers define neurophysiological subtypes of depression.

Authors:  Andrew T Drysdale; Logan Grosenick; Jonathan Downar; Katharine Dunlop; Farrokh Mansouri; Yue Meng; Robert N Fetcho; Benjamin Zebley; Desmond J Oathes; Amit Etkin; Alan F Schatzberg; Keith Sudheimer; Jennifer Keller; Helen S Mayberg; Faith M Gunning; George S Alexopoulos; Michael D Fox; Alvaro Pascual-Leone; Henning U Voss; B J Casey; Marc J Dubin; Conor Liston
Journal:  Nat Med       Date:  2016-12-05       Impact factor: 53.440

Review 8.  Cognitive dysfunction in unipolar depression: implications for treatment.

Authors:  Madhukar H Trivedi; Tracy L Greer
Journal:  J Affect Disord       Date:  2013-09-25       Impact factor: 4.839

9.  MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes.

Authors:  Juan Pablo Lopez; Laura M Fiori; Cristiana Cruceanu; Rixing Lin; Benoit Labonte; Hannah M Cates; Elizabeth A Heller; Vincent Vialou; Stacy M Ku; Christophe Gerald; Ming-Hu Han; Jane Foster; Benicio N Frey; Claudio N Soares; Daniel J Müller; Faranak Farzan; Francesco Leri; Glenda M MacQueen; Harriet Feilotter; Kathrin Tyryshkin; Kenneth R Evans; Peter Giacobbe; Pierre Blier; Raymond W Lam; Roumen Milev; Sagar V Parikh; Susan Rotzinger; Steven C Strother; Cathryn M Lewis; Katherine J Aitchison; Gayle M Wittenberg; Naguib Mechawar; Eric J Nestler; Rudolf Uher; Sidney H Kennedy; Gustavo Turecki
Journal:  Nat Commun       Date:  2017-05-22       Impact factor: 14.919

10.  Anhedonia in schizophrenia and major depression: state or trait?

Authors:  Lorenzo Pelizza; Alberto Ferrari
Journal:  Ann Gen Psychiatry       Date:  2009-10-08       Impact factor: 3.455
View more
  1 in total

1.  Association between Depression, Antidepression Medications, and the Risk of Developing Type 2 Diabetes Mellitus: A Nationwide Population-Based Retrospective Cohort Study in Taiwan.

Authors:  Yi-Jen Fang; Tien-Yuan Wu; Jung-Nien Lai; Cheng-Li Lin; Ni Tien; Yun-Ping Lim
Journal:  Biomed Res Int       Date:  2021-01-07       Impact factor: 3.411
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.